ArticlePharmaceuticals (Basel, Switzerland)2022

Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer's Disease, in Silico Trials.

Dariusz Świetlik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.